Anti-CCL16 immunotoxin FD441.8 (IgG)-RTA (AGTO-G075R)
This immunotoxin was achieved by conjugating/fusing the Anti-CCL16 monoclonal antibody to ricin toxin. It was expressed in CHO and purified with affinity chromatography. The immunotoxin selectively binds to CCL16 positive cells. Then the ricin A chain is incorporated into the cell by receptor-mediated endocytosis, blocking ribosomal protein synthesis and ultimately leading to cell death. It was designed for treatment of Graft-versus-host disease (GVHD).
- Species Reactivity
- Molecule Class
- Toxin Description
- Ricin consist of two polypeptide chains, A and B, linked by means of disulfide bridge(s). Cytotoxicity is associated with the A chain and its 15 inhibition of protein synthesis in nucleated cells. The B chain is essentially a delivery vehicle for the A chain. The B chain recognizes polysaccharide units at the surface of cells and creates a high affinity interaction with such units. Once the B chain binds with polysaccharide units at 20" the celL surface, the A chain is incorporated into the cell, blocking ribosomal protein synthesis and ultimately leading tocell death. The use of ricin A chain is preferred in this invention.
- This product is suitable for use in cytotoxicity assay, functional assay and immunotherapy.
- Related Disease
- Graft-versus-host disease (GVHD)
- Alternative Names
- CCL16; chemokine (C-C motif) ligand 16; LEC; LMC; NCC4; CKb12; HCC-4; LCC-1
- Entrez Gene ID
- UniProt ID
For lab research use only, not for diagnostic, therapeutic or any in vivo human use.
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us